ZBH Zimmer Biomet Loading...

From ZBH earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
12:30
Aug 05 ◎
Ivan Tornos Chairman, President and CEO, Zimmer Biomet Holdings, Inc. ZBH Q2 FY26 call
Management is confident, raising both organic growth and adjusted EPS guidance for the full year based on strong first-half performance, successful sales force transformation, and product momentum.
ZBH
HIGH
12:30
Apr 28 ◎
Yvonne Tornos Chairman, President & CEO, Zimmer Biomet Holdings, Inc. ZBH Q1 FY26 call
Despite beating expectations, management is maintaining a confident but measured tone, noting that the year is a transition period. While they raised EPS and FCF guidance, they left revenue unchanged, preferring to wait 90 days before reassessing.
ZBH
HIGH
13:30
Feb 10 ◎
Yvonne Tornos Chairman, President & CEO, Zimmer Biomet Holdings, Inc. ZBH Q4 FY25 call
Management's tone is cautious, guiding to low-single-digit growth in 2026, explicitly citing short-term disruption from a massive US sales force restructuring which outweighs a strong Q4 exit rate.
ZBH
HIGH

About ZBH Analyst Coverage

Buzzberg tracks ZBH (Zimmer Biomet) across 1 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: Ivan Tornos, Yvonne Tornos.